Although the trial has several limitations, children in the low sugar group scored significantly lower across multiple measures of obesity, including BMI, weight, skinfold-thickness measurements, waist-to-height ratio, and fat mass.
Despite some limitations of trial design, including the open label nature of the study, RECORD remains the only randomized trial of cardiovascular outcomes for Avandia at this time.